You are here
3.2 Metofluthrin
Part A - Final decisions on matters referred to an expert advisory committee (November 2017)
3. Advisory Committee on Chemicals Scheduling (ACCS #21)
3.2 Metofluthrin
On this page: Delegate's final decision | Public submissions on the interim decision |Interim decision | Scheduling proposal
Delegate's final decision
Final decision:
The delegate's final decision is to amend the Schedule 5 entry for metofluthrin by removing the phrase "for use as a mosquito repellent" from subclause (b) as follows:
Schedule 5 - Amend Entry
METOFLUTHRIN:
- in impregnated fabric mosquito repellent preparations for use in a vaporiser containing 15 mg or less of metofluthrin per disk; or
- when impregnated into a polyethylene slow release matrix containing 250 mg or less of metofluthrin.
Implementation date: 1 June 2018
Reasons:
As no new evidence has been received to alter the interim decision for metofluthrin, the delegate has confirmed that the final decision and reasons for the final decision are identical to the interim decision.
Public submissions on the interim decision
No public submissions were received.
Interim decision
The interim decision for metafluthrin was published on the TGA website on 5 February 2018 at Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017 - 3.2. Metafluthrin.
Scheduling proposal
The pre-meeting scheduling proposal for metafluthrin was published on the TGA website on 6 September 2017 at Consultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, November 2017.